CH
ACHV icon

CVI Holdings’s Achieve Life Sciences ACHV Stock Holding History

CVI Holdings’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$337K Sell
71,749
-495,443
-87% -$2.39M 0.29% 37
2024
Q1 		$2.58M Buy
+567,192
New +$2.52M 2.43% 7
2023
Q3 		– Sell
-11,200
Closed -$58.1K – 230
2023
Q2 		$58.1K Buy
+11,200
New +$78.6K 0.06% 75
2020
Q3 		– Sell
-91,463
Closed -$726K – 83
2020
Q2 		$726K Buy
+91,463
New +$729K 0.27% 40
2020
Q1 		– Sell
-58,497
Closed -$620K – 38
2019
Q4 		$620K Buy
+58,497
New +$1.25M 0.87% 16

Other funds holding ACHV

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

CVI Holdings's ACHV Position: Q2 2024 in Review

CVI Holdings reduced its Achieve Life Sciences (ACHV) stake by 87% in Q2 2024, selling an estimated $2.39M and leaving 71,749 shares worth $337K. The position accounts for 0.29% of the portfolio, ranked #37.

CVI Holdings first reported a position in ACHV in Q4 2019 and has held it in 5 quarters since. The position peaked at $2.58M in Q1 2024. 56 funds tracked by Wall St. Rank hold ACHV as of Q2 2024.

  • CVI Holdings held 71,749 shares of Achieve Life Sciences worth $337K as of Q2 2024.
  • CVI Holdings sold 495,443 Achieve Life Sciences shares in Q2 2024, an estimated $2.39M.
  • Achieve Life Sciences made up 0.29% of CVI Holdings's portfolio in Q2 2024, its #37 holding.
  • CVI Holdings first reported a position in Achieve Life Sciences in Q4 2019 and has held it in 5 quarters since.
  • CVI Holdings's Achieve Life Sciences position peaked at $2.58M in Q1 2024.
  • 56 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2024.

Based on CVI Holdings's 13F filing for Q2 2024, filed 15 Aug 2024.